Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Penumbra, Inc. (PEN)
Last penumbra, inc. earnings: 2/25 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.penumbrainc.com/overview/default.aspx
Company Research
Source: Yahoo! Finance
ALAMEDA, Calif. Feb. 25, 2026 /PRNewswire/ -- Penumbra, Inc. NYSE: PEN , the world's leading thrombectomy company, today reported financial results for the fourth quarter and full year ended December 31, 2025. Penumbra, Inc. (PRNewsfoto/Penumbra, Inc.) Financial Highlights: Revenue of $385.4 million for the fourth quarter of 2025, an increase of 22.1% or 20.9% in constant currency , compared to the fourth quarter of 2024. Revenue of $1,403.7 million for the full year 2025, an increase of 17.5% or 16.9% in constant currency , compared to the full year 2024. U.S. Thrombectomy revenue of $203.1 million for the fourth quarter of 2025, an increase of 12.4% compared to the fourth quarter of 2024. U.S. Thrombectomy revenue of $771.5 million for the full year 2025, an increase of 19.3% compared to the full year 2024. Income from operations of $59.2 million or operating margin of 15.4% for the fourth quarter of 2025. Income from operations of $189.2 million or operating margin
Show less
Read more
Impact Snapshot
Event Time:
PEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PEN alerts
High impacting Penumbra, Inc. news events
Weekly update
A roundup of the hottest topics
PEN
News
- Surviving a silent threat: A young mother's journey with pulmonary embolism [CBS News]CBS News
- Penumbra (PEN) had its "neutral" rating reaffirmed by UBS Group AG.MarketBeat
- Penumbra (PEN) had its "outperform" rating reaffirmed by Evercore Inc.MarketBeat
- Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial ResultsPR Newswire
- Halper Sadeh LLC is Investigating Whether PEN, CVGW, SNCY, BKKT are Obtaining Fair Deals for their ShareholdersGlobeNewswire
PEN
Earnings
- 2/25/26 - Beat
PEN
Sec Filings
- 3/4/26 - Form 4
- 3/3/26 - Form 425
- 3/2/26 - Form 144
- PEN's page on the SEC website